Literature DB >> 15700980

Migrastatin and dorrigocins are shunt metabolites of iso-migrastatin.

Jianhua Ju1, Si-Kyu Lim, Hui Jiang, Ben Shen.   

Abstract

Fermentation of Streptomyces platensis NRRL18993 typically accumulated migrastation (1), dorrigocin A (2) and B (3), and 13-epi-dorrigocin A (5). Supplement of XAD-16 resin to the fermentation, in contrast, resulted in exclusive production of iso-migrastatin (4). In vitro studies showed that 1, 2, 3, and 5 are stable in aqueous solution but 4 undergoes rapid conversion into 1, 2, 3, and 5 under the same condition. These results revealed that 4 is the only bona fide natural product biosynthesized by S. platensis, and 1, 2, 3, and 5 are shunt metabolites of 4. This study also established the stereochemistry of 2-5 with the exception of C-11 for 3 and 4. A mechanism for H2O-mediated regio- and stereospecific rearrangement of 4 to 1, 2, 3, and 5 is proposed and supported by incorporation of 18O from H218O.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700980     DOI: 10.1021/ja043808i

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  18 in total

1.  Synthesis and evaluation of antimigratory and antiproliferative activities of lipid-linked [13]-macro-dilactones.

Authors:  Anniefer N Magpusao; Richard T Desmond; Katelyn J Billings; Gabriel Fenteany; Mark W Peczuh
Journal:  Bioorg Med Chem Lett       Date:  2010-07-25       Impact factor: 2.823

2.  Thermolysis of isomigrastatin and its congeners via [3,3]-sigmatropic rearrangement: a new route to the synthesis of migrastatin and its analogues.

Authors:  Jianhua Ju; Si-Kyu Lim; Hui Jiang; Jeong-Woo Seo; Yeng Her; Ben Shen
Journal:  Org Lett       Date:  2006-12-07       Impact factor: 6.005

3.  Garbled messages and corrupted translations.

Authors:  Tilman Schneider-Poetsch; Takeo Usui; Daisuke Kaida; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 4.  Challenges and opportunities for natural product discovery, production, and engineering in native producers versus heterologous hosts.

Authors:  Christiana N Teijaro; Ajeeth Adhikari; Ben Shen
Journal:  J Ind Microbiol Biotechnol       Date:  2018-11-13       Impact factor: 3.346

5.  Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.

Authors:  Margot Carocci; Priscilla L Yang
Journal:  Antiviral Res       Date:  2016-02-10       Impact factor: 5.970

6.  Iso-migrastatin Titer Improvement in the Engineered Streptomyces lividans SB11002 Strain by Optimization of Fermentation Conditions.

Authors:  Xueyun Wu; Dong Yang; Xiangcheng Zhu; Zhiyang Feng; Zhengbin Lv; Yaozhou Zhang; Ben Shen; Zhinan Xu
Journal:  Biotechnol Bioprocess Eng       Date:  2010-08-01       Impact factor: 2.836

7.  Titer improvement of iso-migrastatin in selected heterologous Streptomyces hosts and related analysis of mRNA expression by quantitative RT-PCR.

Authors:  Dong Yang; Xiangcheng Zhu; Xueyun Wu; Zhiyang Feng; Lei Huang; Ben Shen; Zhinan Xu
Journal:  Appl Microbiol Biotechnol       Date:  2010-12-04       Impact factor: 4.813

8.  Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin.

Authors:  Tilman Schneider-Poetsch; Jianhua Ju; Daniel E Eyler; Yongjun Dang; Shridhar Bhat; William C Merrick; Rachel Green; Ben Shen; Jun O Liu
Journal:  Nat Chem Biol       Date:  2010-01-31       Impact factor: 15.040

9.  Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency.

Authors:  Jianhua Ju; Scott R Rajski; Si-Kyu Lim; Jeong-Woo Seo; Noël R Peters; F Michael Hoffmann; Ben Shen
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

10.  Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration.

Authors:  Jianhua Ju; Scott R Rajski; Si-Kyu Lim; Jeong-Woo Seo; Noël R Peters; F Michael Hoffmann; Ben Shen
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.